Department of Biochemistry, Research Unit of Microbiology and Antimicrobial Substances, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon.
Department of Chemistry, Research Unit of Applied and Environmental Chemistry, Faculty of Science, University of Dschang, P.O. Box 67, Dschang, Cameroon.
BMC Complement Med Ther. 2021 Jun 5;21(1):164. doi: 10.1186/s12906-021-03325-y.
Antibiotic resistance has contributed to the burden of infectious diseases both in the hospital and community setting, and represents a great threat to public health. Previous studies have revealed the role of reactive oxygen species as intermediate mediators of tissue damage, following antibiotherapies, indicating the need of associating antioxidants to these treatments. Therefore, the present work was designed to study the antibacterial, antifungal and antioxidant activities of extracts and compounds from Rumex abyssinicus Jacq. (Polygonaceae), as well as to investigate the antibacterial mechanisms of action of the most effective agents.
The plant extracts were prepared by maceration in organic solvents followed by column chromatography of the EtOAc fraction and purification of different fractions which led to the isolation and characterization of pure compounds. The antimicrobial activities of the extracts/compounds and their combinations with ciprofloxacin and fluconazole were evaluated using the broth microdilution method by determining the minimum inhibitory concentration (MIC) and minimum microbicidal concentration (MMC). The effects of the extracts on the bacterial cell membrane and microbial respiratory chain dehydrogenase enzyme activity were determined by spectrophotometric methods. Antioxidant activity was evaluated using 1,1-diphenyl-2-picrylhydrazyl (DPPH) and gallic acid equivalent antioxidant capacity (GAEAC) assays.
Chrysophanol (1), physcion (2), Ergosta-6,22-diene-3,5,8-triol (3), emodin (4), 6-hydroxyemodin (citreorosein) (5), chrysophanein (6) and physcionin (7) were isolated from EtOAc fraction of R. abyssinicus and displayed different degrees of antimicrobial activities (MIC = 8-256 μg/mL). The MeOH extract and compounds 2 and 4 exhibited synergistic effects with ciprofloxacin and fluconazole. Compounds 1, 2 and the combined mixture of 6 + 7 displayed the highest antioxidant activity (GAEAC = 83.38-106.03 μg/mL).
R. abyssinicus is a potential source of antibacterial, antifungal and antioxidant agents. The antibacterial mechanisms of action of the MeOH extract and compound 2 are due to disruption of the cytoplasmic membrane and inhibition of the microbial respiratory chain dehydrogenase enzyme activity. To the best of our knowledge, this is the first report of test samples and ciprofloxacin / fluconazole association against MDR strains. The observed activity of the isolated compounds against bacteria and fungi including MDR strains deserves further exploration.
抗生素耐药性不仅在医院环境中,而且在社区环境中都导致了传染病负担的增加,对公共健康构成了巨大威胁。先前的研究表明,活性氧作为组织损伤的中间介质,在抗生素治疗后发挥作用,这表明需要将抗氧化剂与这些治疗方法联合使用。因此,本研究旨在研究来自 R. abyssinicus Jacq.(蓼科)的提取物和化合物的抗菌、抗真菌和抗氧化活性,并研究最有效试剂的抗菌作用机制。
通过有机溶剂浸提制备植物提取物,然后对 EtOAc 部分进行柱层析,对不同部分进行纯化,得到纯化合物的分离和鉴定。采用肉汤微量稀释法测定最小抑菌浓度(MIC)和最小杀菌浓度(MMC),评估提取物/化合物及其与环丙沙星和氟康唑联合使用的抗菌活性。通过分光光度法测定提取物对细菌细胞膜和微生物呼吸链脱氢酶活性的影响。采用 1,1-二苯基-2-苦基肼(DPPH)和没食子酸当量抗氧化能力(GAEAC)测定法评估抗氧化活性。
从 R. abyssinicus 的 EtOAc 部分分离得到大黄酚(1)、大黄素(2)、麦角甾-6,22-二烯-3,5,8-三醇(3)、大黄素(4)、6-羟基大黄素(大黄酸)(5)、大黄素(6)和大黄素(7),并显示出不同程度的抗菌活性(MIC=8-256μg/mL)。MeOH 提取物、化合物 2 和 4 与环丙沙星和氟康唑具有协同作用。化合物 1、2 和 6+7 的混合混合物表现出最高的抗氧化活性(GAEAC=83.38-106.03μg/mL)。
R. abyssinicus 是一种具有抗菌、抗真菌和抗氧化活性的潜在来源。MeOH 提取物和化合物 2 的抗菌作用机制是由于细胞质膜的破坏和微生物呼吸链脱氢酶活性的抑制。据我们所知,这是首次报道测试样品和环丙沙星/氟康唑联合使用对抗多重耐药菌株。分离化合物对细菌和真菌(包括多重耐药菌株)的活性值得进一步探索。